Metabolic modulation and cellular therapy of cardiac dysfunction and failure: Contractility in Health and Disease Review Series

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 5, 2009, Pages 811-825

  Revenco, Diana ^a   Morgan, James P ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Cardiac regeneration; Cardiac stem cells; Endothelial progenitor cells; Etomoxir; Haematopoietic stem cells; Heart failure; Metabolic modulators; Perhexiline; Stem cells; Trimetazidine

Indexed keywords

ACETYL COENZYME A ACYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; CARNITINE PALMITOYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT STEM CELL; ARTICLE; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; EMBRYONIC STEM CELL; HEART FAILURE; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MYOBLAST; OXIDATIVE PHOSPHORYLATION; REGENERATION; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ACETYL-COA C-ACYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; ADULT STEM CELLS; CARNITINE O-PALMITOYLTRANSFERASE; EMBRYONIC STEM CELLS; HEART FAILURE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE, SKELETAL; MYOBLASTS; OXIDATIVE PHOSPHORYLATION; PPAR GAMMA; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 67249122174     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00759.x     Document Type: Article

References (166)

1. Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DE. The epidemiology of heart failure. Eur Heart J. 1997 2 : 208 25.
2. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant. 1994 13 : S107 12.
3. Levy D, Kenchaiah S, Larson MG, Benjamin EG, Kupka MJ, Ho KK, Murabito JM, Vasan RS. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002 347 : 1397 402.
4. MacIntyre K, Capewell S, Stewart S, Chalmers JWT, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJV. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000 102 : 1126 31.
5. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn B P, Jacobsen SJ. Trends in heart failure incidence and survival in a community-based population. JAMA. 2004 292 : 344 50.
6. Schaufelberger M, Swedberg K, Koster M, Rosen M, Rosengren A. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; data from the Swedish Hospital Discharge Registry 1988 to 2000. Eur Heart J. 2004 25 : 300 7.
7. Stewart S, MacIntyre K, Hole DJ, Capewell S, McMurray JJ. More 'malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail. 2001 3 : 315 22.
8. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. ACC-AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology-American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 112 : e154 235.
9. Goodlin SJ, Hauptman PJ, Arnold R, Grady K, Hershberger RE, Kurtner J. Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail. 2004 10 : 200 9.
10. Gertz EW, Wisneski JA, Stanley WC, Neese RA. Myocardial substrate utilization during exercise in humans dual carbon-labeled carbohydrate isotope experiments. J Clin Invest. 1988 82 : 2017 25.
11. Young LH, Coven DL, Russell RR, 3rd. Cellular and molecular regulation of cardiac glucose transport. J Nucl Cardiol. 2000 7 : 267 76.
12. Young LH, Renfu Y, Russell R, Hu X, Caplan M, Ren J, Shulman GI, Sinusas AJ. Low-flow ischemia leads to transloca-tion of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 1997 95 : 415 22.
13. Xing Y, Musi N, Fujii N, Zou L, Luptak I, Hirshman MF, Goodyear LJ, Tian R. Glucose metabolism and energy home-ostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J Biol Chem. 2003 278 : 28372 7.
14. Russell RR, 3rd., Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest. 2004 114 : 495 503. (Pubitemid 39572099)
15. Depre C, Rider MH, Hue L. Mechanisms of control of heart glycolysis. Eur J Biochem. 1998 258 : 277 90.
16. Kaijser L, Berglund B. Myocardial lactate extraction and release at rest and during heavy exercise in healthy men. Acta Physiol Scand. 1992 144 : 39 45.
17. Stanley WC. Myocardial lactate metabolism during exercise. Med Sci Sports Exerc. 1991 23 : 920 4.
18. Bing RJ, Siegel A, Ungar I, Gilbert M. Metabolism of the human heart II studies on fat, ketone and amino acid metabolism. Am J Med. 1954 16 : 504 15.
19. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta. 1994 1213 : 263 76.
20. Augustus AS, Kako Y, Yagyu H, Goldberg IJ. Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab. 2003 284 : E331 9.
21. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res. 2002 43 : 1997 2006. (Pubitemid 35471065)
22. van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000 45 : 279 93.
23. Schaffer JE. Fatty acid transport: the roads taken. Am J Physiol Endocrinol Metab. 2002 282 : E239 46.
24. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med. 2002 53 : 409 35.
25. Huang B, Wu P, Bowker-Kinley MM, Harris RA. Regulation of pyruvate dehy-drogenase kinase expression by peroxi-some proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes. 2002 51 : 276 83.
26. Gilde AJ, Van Der Lee KA, Willemsen PH, Chinetti G, Van Der Leij FR, Van Der Vusse GJ, Staels B, Van Bilsen M. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta-delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res. 2003 92 : 518 24.
27. Harris RA, Huang B, Wu P. Control of pyruvate dehydrogenase kinase gene expression. Adv Enzyme Regul. 2001 41 : 269 88.
28. Goodwin GW, Taegtmeyer H. Regulation of fatty acid oxidation of the heart by MCD and ACC during contractile stimulation. Am J Physiol. 1999 277 : E772 7.
29. Saddik M, Gamble J, Witters LA, Lopaschuk GD. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. J Biol Chem. 1993 268 : 25836 45.
30. Neubauer S. The failing heart - an engine out of fuel. N Engl J Med. 2007 356 : 1140 51.
31. Bessman SP, Geiger PJ. Transport of energy in muscle: the phosphorylcreatine shuttle. Science. 1981 211 : 448 52.
32. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005 85 : 1093 129.
33. Fisher DJ, Heymann MA, Rudolph AM. Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep. Am J Physiol. 1980 238 : H399 405.
34. Makinde AO, Gamble J, Lopaschuk GD. Upregulation of 5'-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circ Res. 1997 80 : 482 9.
35. Itoi T, Lopaschuk GD. The contribution of glycolysis, glucose oxidation, lactate oxidation, and fatty acid oxidation to ATP production in isolated biventricular working hearts from 2-week-old rabbits. Pediatr Res. 1993 34 : 735 41.
36. Kantor PF, Robertson MA, Coe JY, Lopaschuk GD. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism. J Am Coll Cardiol. 1999 33 : 1724 34.
37. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Morris DL, Craig JC. Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest. 1985 76 : 1819 27.
38. Wisneski JA, Gertz EW, Neese RA, Mayr M. Myocardial metabolism of free fatty acids Studies with 14C-labeled substrates in humans. J Clin Invest. 1987 79 : 359 66.
39. Sultan AM. Effects of diabetes and insulin on ketone bodies metabolism in heart. Mol Cell Biochem. 1992 110 : 17 23.
40. Chandler M P, Kerner J, Huang H, Vasquez E, Reszko A, Martini WZ, Hoppel Cl, Imai M, Rastogi S, Sabbah HN, Stanley WC. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol. 2004 287 : H1538 43.
41. Recchia FA, McConnell PI, Bernstein RD, Vogel TR, Xu X, Hintze TH. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. Circ Res. 1998 83 : 969 79.
42. Chandler MP, Stanley WC, Morita H, Suzuki G, Roth BA, Blackburn B, Wolff A, Sabbah HN. Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure. Circ Res. 2002 91 : 278 80.
43. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 2002 51 : 2005 11.
44. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004 25 : 543 67.
45. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res. 2006 98 : 596 605. (Pubitemid 43755278)
46. Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, Carey C, Macdermott S, Russel-Eggitt I, Shea SE, Davis J, Beck S, Shatirishvili G, Mihai CM, Hoeltzenbein M, Pozzan GB, Hopkinson I, Sicolo N, Naggert JK, Nishina PM. New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 2005 165 : 675 83.
47. Nikolaidis LA, Sturzu A, Stolarski C, Elahi D, Shen YT, Shannon RP. The development of myocardial insulin resistance in conscious dogs with advanced dilated car-diomyopathy. Cardiovasc Res. 2004 61 : 297 306. (Pubitemid 38091770)
48. Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP. Glucagon-like pep-tide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail. 2006 12 : 694 9.
49. Eshaghian S, Horwich TB, Fonarow GC. Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol. 2006 97 : 1759 64.
50. Ahmed A, Husain A, Love TE, Gambassi G, Dell'Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC. Heart failure, chronic diuretic use, and increase in mortality and hospital-ization: an observational study using propensity score methods. Eur Heart J. 2006 27 : 1431 9.
51. Borst P, Loos JA, Christ EJ, Slater EC. Uncoupling activity of long-chain fatty acids. Biochim Biophys Acta. 1962 62 : 509 18.
52. Opie LH. The metabolic vicious cycle in heart failure. Lancet. 2004 364 : 1733 4.
53. Sabbah HN, Sharov V, Riddle JM, Kono T, Lesch M, Goldstein S. Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol. 1992 24 : 1333 47.
54. Casademont J, Miro O. Electron transport chain defects in heart failure. Heart Fail Rev. 2002 7 : 131 9.
55. Schaper J, Froede R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991 83 : 504 14.
56. Scheubel RJ, Tostlebe M, Simm A, Rohrbach S, Prondzinski R, Gellerich FN, Silber RE, Holtz J. Dysfunction of mito-chondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression. J Am Coll Cardiol. 2002 40 : 2174 81.
57. Marin-Garcia J, Goldenthal MJ, Moe GW. Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc Res. 2001 52 : 103 10.
58. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, Uchida K Arimura K, Egashira K, Takeshita A. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res. 1999 85 : 357 63.
59. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol. 2000 278 : H1345 51.
60. Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol. 2004 555 : 1 13. (Pubitemid 38313058)
61. Miyamoto T, Takeishi Y, Tazawa S, Inoue M, Aoyama T, Takahashi H, Arimoto T, Shishido T, Tomoike H, Kubota I. Fatty acid metabolism assessed by 125 I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts. Eur J Clin Invest. 2004 34 : 176 81.
62. lemitsu M, Miyauchi T, Maeda S, Tanabe T, Takanashi M, Irukayama-Tomobe Y, Sakai S, Ohmori H, Matsuda M, Yamaguchi I. Aging-induced decrease in PPARa level in hearts is improved by exercise training. Am J Physiol Heart Circ Physiol. 2002 283 : H1750 60.
63. Karbowska J, Kochan Z, Smolenski RT. Peroxisome proliferator-activated receptor alpha is downregulated in the failing human heart. Cell Mol Biol Lett. 2003 8 : 49 53. (Pubitemid 36534564)
64. Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP. Deactivation of PPARa during cardiac hypertrophic growth. J Clin Invest. 2000 105 : 1723 30.
65. Stavinoha MA, RaySpellicy JW, Essop MF, Graveleau C, Abbel ED, Hart-Sailors ML, Mersmann HJ, Bray MS, Young ME. Evidence for mitochondrial thioesterase 1 as peroxisome proliferator-activated receptor-alpha regulated gene in cardiac and skeletal muscle. Am J Physiol Endocrinol Metab. 2004 287 : E888 95.
66. Young ME, Patll S, Ylng J, Depre C, Ahuja HS, Shipley GL, Stepkowskl SM, Davles PJ, Taegtmeyer H. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J. 2001 15 : 833 45.
67. Garlitl KD, Jaburek M, Jezek P, Varecha M. How do uncoupling proteins uncouple? Biochim Biophys Acta. 2000 1459 : 383 9.
68. Garlitl KD, Orosz DE, Modrlansky M, Vassanelll S, Jezek P. On the mechanis-mof fatty acid-induced proton transport by mitochondrial uncoupling protein. J Biol Chem. 1996 271 : 2615 20.
69. Starling RC HD, Altschuld RA. Human myocardial ATP content and in vivo contractile function. Molec Cell Biochem. 1998 150 : 170 7.
70. Nakae I, Mltsunaml K, Omura T, Yabe T, Tsutamoto T, Matsuo S, Takahashl M, Morlkawa S, Inubushl T, Nakamura Y, Kinoshita M, Horie M. Proton magnetic resonance spectroscopy can detect crea-tine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol. 2003 42 : 1587 93.
71. Ingwall JS Weiss RG. Is the failing heart enegy starved? On using chemical energy to support cardiac function. Circ Res. 2004 95 : 135 45.
72. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, Pabst T, Ertl G, Hahn D, Kochslek K. Myocardial phos-phocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomy-opathy. Circulation. 1997 96 : 2190 6.
73. MacInnes A, Fairman DA, Binding P, Rhodes J, Wyatt MJ, Phelan A, Haddock PS, Karran EH. The antianginal agent trimetazidine does not exert its functional benefit via inhibition of mitochondrial long-chain 3-ketoacyl coenzyme A thio-lase. Circ Res. 2003 93 : 26 32.
74. Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coen-zyme A thiolase. Circ Res. 2000 86 : 580 8.
75. Fragasso G Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure. J Am Coll Cardiol. 2006 48 : 992 5.
76. Di Napoli P, Taccardi AA, Barsotti A. Long term cardioprotective action of trimetazi-dine and potential effect on the inflammatory process in patients with ischaemic dialted cardiomyopathy. Heart. 2005 91 : 161 5.
77. Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur Heart J. 2004 25 : 1814 21.
78. Rosano GM, Vitale C, Sposato B, Mercuro G, Fini M. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double bind placebo-controlled study. Cardiovasc Diabetol. 2003 2 : 16 24.
79. Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomy-opathy: a post-hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial. J Cardiovasc Pharmacol. 2007 50 : 585 9.
80. Lee L Campbell R, Scheuermann-Freestone M, Taylor R, Williams L, Ashrafian H, Horowitz J, Fraser AG, Clarke K, Frenneaux M. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation. 2005 112 : 3280 8.
81. Turcani M, Rupp H. Modification of left ventricular hypertrophy by chronic etomixir treatment. Br J Pharmacol. 1999 126 : 501 7.
82. Schmidt-Schweda S, Holubasch C. First clinical trial with etomoxir in patients with chronic congestive heart failure. Clin Sci. 2000 99 : 27 35. (Pubitemid 30479390)
83. Dobbins RL, Szczepaniak LS, Bentley B, Esser V, Myhill J, McGarry GD. Prolonged inhibition of muscle CPT-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes. 2001 50 : 123 30.
84. Lionetti V, Linke A, Chandler M P, Young ME, Penn MS, Gupte S, d'Agostino C, Hintze TH, Recchia FA. Carnitine palmitoyl transferase01 inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure. Cardiovasc Res. 2001 66 : 454 61.
85. Shiomi T, Tsutsui H, Hayashidani S, Suematsu N, Ikeuchi M, Wen J, Ishibashi M, Kubota T, Egashira K, Takeshita A. Pioglitazone a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation. 2002 106 : 3126 32.
86. Lygate CA, Hulbert K, Monfared M, Cole MA, Clarke K, Neubauer S. The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction. Cardiovasc Res. 2003 58 : 632 7.
87. Karsner HT, Saphir O, Todd TW. The state of the cardiac muscle in hypertrophy an atrophy. Am J Pathol. 1925 1 : 351 71.
88. Morkin E, Ashford TP. Myocardial DNA synthesis in experimental cardiac hypertrophy. Am J Physiol. 1968 215 : 1409 13.
89. Leri A, Malhotra A, Liew CC, Kajstura J, Anversa P. Telomerase activity in rat cardiac myocytes is age and gender dependent. J Mol Cell Cardiol. 2000 32 : 385 90.
90. Grajek S, Lesiak M, Pyda M, Zajac M, Paradowski S, Kaczmarek E. Hypertrophy or hyperplasia in cardiac muscle: postmortem human morphometric study. Eur Heart J. 1993 14 : 40 7.
91. Olivetti G, Melissari M, Balbi T, Quaini F, Sonnenblick EH, Anversa P. Myocyte nuclear and possible cellular hyperplasia contribute to ventricular remodeling in hypertrophic senescent heart in humans. J Am Coll Cardiol. 1994 24 : 140 9.
92. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA. 1998 95 : 8801 5.
93. Quaini F, Cigola E, Lagrasta C, Saccani G, Rossi C, Olivetti G, Anversa P. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res. 1994 75 : 1050 63.
94. Leri A, Barlucchi L, Limana F, Deptala A, Darzynkiewicz Z, Hintze TH, Kajstura J, Nadal-Ginard B, Anversa P. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telemetric length in the failing heart. Proc Natl Acad Sci USA. 2001 98 : 8626 31.
95. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Chimerism of the transplanted heart. N Engl J Med. 2002 346 : 5 15. (Pubitemid 34438914)
96. Hruban RH, Long PP, Perlman EJ, Hutchins GM, Baumqartner WA, Bauqhman KL, Griffin CA. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol. 1993 142 : 975 80.
97. Glaser R, Lu MM, Narula N, Epstein GJ. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation. 2002 106 : 17 9.
98. Hocht-Zeisberg E, Kahnert H, Guan K, Wulf G, Hemmerlein B, Schlott T, Tenderich G, Korfer R, Raute-Kreinsen U, Hasenfuss G. Cellular repopulation of myocardial infarction in patients with sex-mismatched heart transplantation. Eur Heart J. 2004 25 : 749 58.
99. Anversa P, Kajstura J, Leri A, Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation. 2006 113 : 1451 63.
100. Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res. 2003 93 : 139 50.
101. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Platoshyn O, Yuan JX, Evans S, Chien KR. Postnatal isl1 + cardioblast enter fully differentiated cardiomyocyte lineages. Nature. 2005 433 : 647 53.
102. Anversa P, Palackal T, Sonnenblick EH, Olivetti G, Capasso JM. Hypertensive car-diomyopathy: myocyte nuclei hyperplasia in the mammalian rat heart. J Clin Invest. 1990 85 : 994 7.
103. Urbanek K, Quaini F, Tasca G, Torella D, Castaldo C, Nadal-Ginard B, Leri A, Kajstura J, Quaini E, Anversa P. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci USA. 2003 100 : 10440 5.
104. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994 89 : 151 63.
105. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science. 2002 298 : 2188 90.
106. Murry CE, Wiseman R, Schwartz SM, Hauschka SD. Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest. 1996 98 : 2512 23.
107. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell. 2004 116 : 639 48.
108. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, MacKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infracted myocardium. Nature. 2001 410 : 701 5.
109. Pagani FD, DerSimonian H, Zawadzka A, Wetzel K, Edge AS, Jacoby DB, Dinsmore JH, Wright S, Aretz TH, Eisen HJ, Aaronson KD. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans Histological analysis of cell survival and differentiation. J Am Coll Cardiol. 2003 41 : 879 88.
110. Taylor DA, Atkins BZ, Hungspreugs P, Jones TR, Reedy MC, Hutcheson KA, Glower DD, Kraus WE. Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med. 1998 4 : 929 33.
111. Chiu RC, Zibaitis A, Kao RL. Cellular car-diomyoplasty: myocardial regeneration with satellite cell implantation. Ann Thorac Surg. 1995 60 : 12 8.
112. Bonaros N, Rauf R, Wolf D, Margreiter E, Tzankov A, Schlechta B, Kocher A, Ott H, Schachner T, Hering S, Bonatti J, Laufer G. Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure. J Thorac Cardiovasc Surg. 2006 132 : 1321 8.
113. Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, Xue T, Li RA, O'Rourke B, Marban E. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res. 2005 97 : 159 67.
114. Menasche P, Hagege A, Scorsin M, Pouzet B, Desnos M, Duboc D, Schwartz K, Vilquin JT, Marolleau J P. Myoblast transplantation for heart failure. Lancet. 2001 357 : 279 80.
115. Smits PC, van Geuns RJ, Poldermans D, Bountioukos M, Onderwater EE, Lee CH, Maat A P, Serruys PW. Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. J Am Coll Cardiol. 2003 42 : 2063 9.
116. Dib N, Michler RE, Pagani FD, Wright S, Kereiakis DJ, Lengerich R, Binkley P, Buchele D, Anand I, Swingen C, Di Carli MF, Thomas JD, Jaber WA, Opie SR, Campbell A, McCarthy P, Yeager M, Dilsizian V, Griffith B P, Korn R, Kreuger SK, Ghazoul M, Maclellan WR, Fonarow G, Eisen HJ, Dinsmore J, Diethrich E. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy:four-year follow-up. Circulation. 2005 112 : 1748 55.
117. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H, Benvenisty N. Differentiation of human embryonic stem cells into embryoid bodies comprising the three embryonic germ layers. Mol Med. 2000 6 : 88 95.
118. Leri A, Kanjstura J, Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev. 2005 85 : 1371 416.
119. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol. 2000 18 : 399 404. (Pubitemid 30217526)
120. Ott HC, Matthiesen T, Brechtken J, Grindle S, Goh SK, Nelson W, Taylor DA. The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. Nat Clin Prac Cardiovasc Med. 2007 4 : S27 39.
121. Hodgson DM, Behfar A, Zingman LV, Kane GC, Peres-Terzic C, Alekseev AE, Puceat M, Terzic A. Stable benefit of embryonic stem cell therapy in myocardial infarction. Am J Physiol Heart Circ Physiol. 2004 284 : H471 9.
122. Min JY, Yang Y, Converso KL, Liu L, Huang Q, Morgan JP, Xiao YF. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J Appl Physiol. 2002 92 : 288 96.
123. He JQ, Ma Y, Lee Y, Thompson JA, Kamp TJ. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res. 2003 93 : 32 9.
124. Fijvandraat AC, van Ginneken A, de Boer PA, Ruijter JM, Christoffels VM, Moorman AF, Lekanne Deprez RH. Cardiomyocytes derived from embryonic stem cells resemble cardiomyocytes of embryonic heart tube. Cardiovasc Res. 2003 58 : 399 409. (Pubitemid 36570398)
125. Draper JS, Pigott C, Thomson JA, Andrews PW. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat. 2002 200 : 249 58.
126. Becker AJ, McCulloch EA, Till JE. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature. 1963 197 : 452 4.
127. Uchida N, Weissman IL. Searching for hematopoietic stem cells: evidence that Thy-1.1 Lin-Sca-1 + cells are the only stem cells in C57BL-Ka-Thy11 bone marrow. J Exp Med. 1992 175 : 175 84.
128. Krause DS, Theise ND, Collector Ml, Henegarlu O, Hwang S, Gardner R, Neutzel S, Sharkls SJ. Multi-organ multi-lineage engraftment by a single bone marrow derived stem cell. Cell. 2001 105 : 369 77.
129. Mezey E, Chandross K, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000 290 : 1779 82.
130. Spangrude GJ, Helmfeld S, Welssmen IL. Purification and characterization of mouse hematopoietic stem cells. Science. 1988 241 : 58 62. (Pubitemid 18168116)
131. Orllc D, Kajstura J, Chlmentl S, Llmana F, Jakoniuk I, Qualnl F, Nadal-Glanard B, Bodlne DM, Lerl A, Anversa P. Mobilized bone marrow cells repair in infracted heart improving function and survival. Proc Natl Acad Sci USA. 2001 98 : 10344 9.
132. Fernandez-Avlles F, San Roman JA, Garcla-Frade J, Fernandez ME, Penarrubla MJ, de la Fuente L, Gomez-Bueno M, Cantalapledra A, Fernandez J, Gutierrez O, Sanchez PL, Hernandez C, Sanz R, Garcla-Sancho J, Sanchez A. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ Res. 2004 95 : 742 8.
133. Jackson KA, Majka SM, Wang H, Poclus J, Hartley CJ, Majesky MW, Entman ML, Michael LH, Hlschl KK, Goodell MA. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001 107 : 1395 402.
134. Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzl C, Nurzynska D, Kasahara H, Zlas E, Bonafe M, Nadal-Gianrd B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005 96 : 127 37.
135. Yoon YS, Wecker A, Heyd L, Park J, Tkebuchava T, Kusano K, Hanley A, Scadova H, Qin G, Cha DH, Johnson KL, Aikawa R, Asahara T, Losordo DW. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest. 2005 115 : 326 38.
136. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med. 2001 226 : 507 20.
137. Sanchez-Ramos J, Song S, Cardozo-Pelaez F, Hazzi C, Stedeford T, Willing A, Freeman TB, Saporta S, Janssen W, Patel N, Cooper DR, Sanberg PR. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000 174 : 11 20.
138. Conget PA, Minguell J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol. 1999 182 : 67 73. (Pubitemid 29400373)
139. Smith JR, Pochampally R, Perry A, Hsu SC, Prockop DJ. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells. 2002 22 : 823 31.
140. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multlineage potential of adult human mesenchymal stem cells. Science. 1999 284 : 143 7.
141. Silva GV, Litovski S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005 111 : 150 6.
142. Onishchenko NA, Potapov IV, Bashkina LA, Krashenennikov ME, Zaidenov VA, Avramov PV. Recovery of contractile function of cryodamaged rat myocardium after transplantation of fetal cardiomyocytes and predifferentiation bone marrow stromal cells. Bull Exp Biol Med. 2004 138 : 357 60.
143. Vulliet PR, Greeley M, Halloran SM, MacDonald KA, Kittleson MD. Intracoronary arterial injection of the mes-enchymal stromal cells and microinfarc-tion in dogs. Lancet. 2004 363 : 783 4.
144. Gehllng UM, Erqun S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Klllc N, Kluge K, Schafer B, Hossfeld DK, Fiedler W. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood. 2000 95 : 3106 12.
145. Pelchev M, Nalyer AJ, Perelra D, Zhu Z, Lane WJ, Williams M, Oz MC, Hlcklln DJ, Wltte L, Moore MA, Rafll S. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood. 2000 95 : 952 8.
146. Rehman J LJ, Orschell CM, March KL. Peripheral blood "endothelial progenitor cells" are derived for monocyte-macrophages and secrete angiogenic growth factors. Circulation. 2003 107 : 1164 69.
147. Yoshloka T, Ageyama N, Shlbata H, Yasu T, Mlsawa Y, Takeuchl T, Matsul K, Yamamoto K, Terao K, Shlmada K, Ikeda U, Ozawa K, Hanazono Y. Repair of infracted myocardium mediated y transplanted bone marrow-derived CD34+ stem cells in nonhuman primate model. Stem Cells. 2005 23 : 355 64.
148. Skowasch D, Jabs A, Andrle R, Dinkelbach S, Luderltz B, Baurledel G. Presence of bone-marrow and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis. Cardiovasc Res. 2003 60 : 684 91.
149. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, Yeh ET. Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD-34-positive cells into cardyomyocytes in vivo. Circulation. 2004 110 : 3803 7.
150. Balsam LB, Wagers A, Chrlstensen JL, Kofldls T, Weissman IL, Robblns RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature. 2004 428 : 668 73.
151. Beltrami AP, Barlucchl L, Torella D, Baker M, Llmana F, Chlmentl S, Kasahara H, Rota M, Musso E, Urbanek K, Lerl A, Kajstura J, Nadal-Glnard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003 114 : 763 76.
152. Chlmentl C, Kajstura J, Torella D, Urbanek K, Helenlak H, Colussl C, Di Megllo F, Nadal-Glnard B, Frustacl A, Leri A, Maseri A, Anversa P. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res. 2003 93 : 604 13.
153. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol. 2002 30 : 973 81.
154. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasurmathi KB, Viraq JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Hematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature. 2004 428 : 664 8.
155. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002 416 : 542 5.
156. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents car-diomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001 4 : 430 6.
157. Munoz JR, Stoutenger B, Robinson AP, Spees JL, Prockop DJ. Human stem-progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA. 2005 102 : 18171 6.
158. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breindenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary autol-ogous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet. 2004 364 : 141 8.
159. Meyer G P, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months follow-up data from the randomized, controlled BOOST (Bone Marrow Transfer to Enhance ST-elevation infarct regeneration) trial. Circulation. 2006 113 : 1287 94.
160. Schachinger V, Tonn T, Dimmeler S, Zeiher AM. Bone-marrow-derived progenitor cell therapy in need of proof of concept: design of the REPAIR-AMI trial. Nat Clin Prac Cardiovasc Med. 2006 3 : S23 8.
161. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Werner N, Germing A, Mark B, Assmus B, Tonn T, Dimmeler S, Zeiher AM, REPAIR-AMI Investigators. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1 year results of the REPAIR-AMI trial. Eur Heart J. 2006 27 : 2775 83.
162. Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Forfang K ASTAMI Invetigators. Autologous stem cell transplantation in acute myocardial infarction: The ASTAMI randomized controlled trial. Intracoronary transplantation of autolo-gous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J. 2006 39 : 150 8.
163. Ince H, Petzsch M, Kleine HD, Eckard H, Rehders T, Burska D, Kische S, Freund M, Nienaber CA. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation. 2005 112 : 173 80.
164. Ripa RS, Jorgensen E, Wang Y, Thune JJ, Nilsson JC, Sondergaard L, Johnsen HE, Kober L, Grande P, Kastrup J. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation. 2006 113 : 1983 92.
165. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Martin H, Albomaali ND, Tonn T, Dimmeler S, Zeiher AM. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med. 2006 355 : 1222 32.
166. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, Rossi MI, Carvalho AC, Dutra HS, Dohmann HJ, Silva GV, Belem L, Vivacqua R, Rangel FO, Esporcatte R, Geng YJ, Vauqhn WK, Assad JA, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation. 2003 107 : 2294 302.